Patents by Inventor Todd Anthony Miller

Todd Anthony Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protective enclosures for portable electronic devices and related methods
    Patent number: 9760128
    Abstract: A protective enclosure is provided for securing portable electronic devices within the enclosure. The enclosure generally includes a front structure, a back structure, and at least one bracket. The front structure defines at least one aperture for permitting access to a display of the computing device. The back structure is configured to couple to the front structure. The front structure and back structure are configured to cooperate to substantially enclose at least four corners of the portable computing device. The at least one bracket is configured to engage the front and back structures, and includes a tamper-resistant fastener configured to secure the front and back structures together on the portable computing device.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: September 12, 2017
    Assignee: Cyber Acoustics, LLC
    Inventors: Greg Mitchel Sande, David Dohna Lewin, Todd Anthony Miller
  • Protective Enclosures for Portable Electronic Devices and Related Methods
    Publication number: 20160291643
    Abstract: A protective enclosure is provided for securing portable electronic devices within the enclosure. The enclosure generally includes a front structure, a back structure, and at least one bracket. The front structure defines at least one aperture for permitting access to a display of the computing device. The back structure is configured to couple to the front structure. The front structure and back structure are configured to cooperate to substantially enclose at least four corners of the portable computing device. The at least one bracket is configured to engage the front and back structures, and includes a tamper-resistant fastener configured to secure the front and back structures together on the portable computing device.
    Type: Application
    Filed: May 19, 2015
    Publication date: October 6, 2016
    Inventors: Greg Mitchel Sande, David Dohna Lewin, Todd Anthony Miller
  • Pyrrole substituted 2-indolinone protein kinase inhibitors
    Patent number: 7572924
    Abstract: The present invention relates to pyrrole substituted-2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: September 6, 2006
    Date of Patent: August 11, 2009
    Assignees: Sugen, Inc., Pharmacia & Upjohn Co.
    Inventors: Peng Cho Tang, Todd Anthony Miller, Xiaoyuan Li, Connie Li Sun, Chung Chen Wei, Shahrzad Shirazian, Congxin Liang, Tomas Vojkovsky, Asaad S. Nematalla, Michael Hawley
  • 3-methylidenyl-2-indolinone modulators of protein kinase
    Patent number: 6855730
    Abstract: The present invention relates to novel 3-methylidenyl-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: March 10, 2003
    Date of Patent: February 15, 2005
    Assignee: Sugen, Inc.
    Inventors: Pen Cho Tang, Li Sun, Todd Anthony Miller, Congxin Liang, Ngoc My Tran, Anh Thi Nguyen, Asaad Nematalla
  • Indolinone compounds as kinase inhibitors
    Patent number: 6689806
    Abstract: The invention relates to certain indolinone compounds, their method of synthesis, and a combinatorial library consisting of the indolinone compounds of the invention. The invention also relates to methods of modulating the function of protein kinases using indolinone compounds of the invention and methods of treating diseases by modulating the function of protein kinases and related signal transduction pathways.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: February 10, 2004
    Assignee: Sugen, Inc.
    Inventors: Peng Cho Tang, Li Sun, Gerald McMahon, Todd Anthony Miller, Shahrzad Shirazian, Chung Chen Wei, G. Davis Harris, Jr., Xiaoyuan Li, Congxin Liang
  • 3-methylidenyl-2-indolinone modulators of protein kinase
    Publication number: 20040024010
    Abstract: The present invention relates to novel 3-methylidenyl-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Application
    Filed: March 10, 2003
    Publication date: February 5, 2004
    Applicant: Sugen, Inc.
    Inventors: Pen Cho Tang, Li Sun, Todd Anthony Miller, Congxin Liang, Ngoc My Tran, Anh Thi Nguyen, Asaad Nematalla
  • Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
    Patent number: 6642251
    Abstract: The present invention relates to novel geometrically restricted 2-indolinones and physiologically acceptable salts thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: January 15, 2003
    Date of Patent: November 4, 2003
    Assignee: Sugen, Inc.
    Inventors: Peng Cho Tang, Todd Anthony Miller, Li Sun, Ngoc My Tran, Asaad Nematalla, Anh Thi Nguyen
  • Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
    Publication number: 20030199510
    Abstract: The present invention relates to novel geometrically restricted 2-indolinones and physiologically acceptable salts thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Application
    Filed: January 15, 2003
    Publication date: October 23, 2003
    Applicant: SUGEN, INC.
    Inventors: Peng Cho Tang, Todd Anthony Miller, Li Sun, Ngoc My Tran, Asaad Nematalla, Anh Thi Nguyen
  • 3-Methylidenyl-2-indolinone modulators of protein kinase
    Patent number: 6531502
    Abstract: The present invention relates to novel 3-methylidenyl-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: March 11, 2003
    Assignee: Sugen, Inc.
    Inventors: Pen Cho Tang, Li Sun, Todd Anthony Miller, Congxin Liang, Ngoc My Tran, Anh Thi Nguyen, Asaad Nematalla
  • Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
    Patent number: 6525072
    Abstract: The present invention relates to novel geometrically restricted 2-indolinones and physiologically acceptable salts thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: August 30, 1999
    Date of Patent: February 25, 2003
    Assignee: Sugen, Inc.
    Inventors: Peng Cho Tang, Todd Anthony Miller, Li Sun, Ngoc My Tran, Asaad Nematalla, Anh Thi Nguyen
  • N-substituted glycine derivatives as enzyme inhibitors
    Patent number: 6025472
    Abstract: The present invention discloses peptide aldehydes which are potent inhibitors of factor Xa, their pharmaceutically acceptable salts, pharmaceutically acceptable compositions thereof, and methods of using them as therapeutic agents for disease states in mammals characterized by abnormal thrombosis.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 15, 2000
    Assignee: Corvas International, Inc.
    Inventors: Matthew Mark Abelman, Todd Anthony Miller, Ruth Foelsche Nutt
  • Inhibitors of thrombosis
    Patent number: 5955576
    Abstract: This invention relates to peptide aldehyde analogs that inhibit the thrombin or Factor Xa. The compounds are thought useful for preventing or treating conditions in mammal characterized by abnormal thrombosis.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 21, 1999
    Assignee: Corvas International, Inc.
    Inventors: George Phillip Vlasuk, Thomas Roy Webb, Matthew Mark Abelman, Daniel Andrew Pearson, Todd Anthony Miller
  • Arginine keto-amide enzyme inhibitors
    Patent number: 5869454
    Abstract: The present invention is directed to novel arginine alpha-keto-amide derivatives, their pharmaceutically acceptable salts and compositions thereof which are useful as antithrombotic agents in mammals and also the use of these compounds as antithrombotic agents. Also, described are methods of using these inhibitors as inhibitors of coagulation proteases and as therapeutic agents for disease states characterized by abnormal thrombus formation and/or disorders of the blood coagulation process. Further described herein are compounds useful as intermediates in the preparation of these compounds.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: February 9, 1999
    Assignee: Corvas International, Inc.
    Inventors: Thomas Roy Webb, Todd Anthony Miller, George Phillip Vlasuk, Matthew Mark Abelman
  • N-substituted glycine derivatives as enzyme inhibitors
    Patent number: 5696231
    Abstract: The present invention discloses peptide aldehydes which are potent inhibitors of factor Xa, their pharmaceutically acceptable salts, pharmaceutically acceptable compositions thereof, and methods of using them as therapeutic agents for disease states in mammals characterized by abnormal thrombosis.
    Type: Grant
    Filed: December 21, 1994
    Date of Patent: December 9, 1997
    Assignee: Corvas International, Inc.
    Inventors: Matthew Mark Abelman, Todd Anthony Miller, Ruth Foelsche Nutt